The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)

Atherosclerosis

Volumn 194, Issue 1, 2007, Pages 245-252

  Holvoet, Paul ^a   Jenny, Nancy S ^b   Schreiner, Pamela J ^c   Tracy, Russell P ^b   Jacobs, David R ^c,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Atherosclerosis; Cardiovascular disease; Cardiovascular risk; Lipoproteins; Oxidized LDL

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E6; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGATSTON CALCIUM SCORE; AGED; ANKLE BRACHIAL INDEX; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIVARIATE ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; COHORT ANALYSIS; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; ETHNICITY; FEMALE; GENDER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SMOKING;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 34648839885     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.002     Document Type: Article

References (38)

1. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
2. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494
3. Toshima S., Hasegawa A., Kurabayashi M., Itabe H., Takano T., Sugano J., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20 (2000) 2243-2247
4. Tsimikas S., Bergmark C., Beyer R.W., et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41 (2003) 360-370
5. Tsimikas S., Brilakis E.S., Miller E.R., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353 (2005) 46-57
6. Holvoet P., Harris T.B., Tracy R.P., et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol 23 (2003) 1444-1448
7. Hulthe J., and Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22 (2002) 1162-1167
8. Metso S., Loimaala A., Mercuri M.F., et al. Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men. J Biomed Sci 11 (2004) 356-361
9. Wallenfeldt K., Fagerberg B., Wikstrand J., and Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256 (2004) 413-420
10. Parhami F., Basseri B., Hwang J., Tintut Y., and Demer L.L. High-density lipoprotein regulates calcification of vascular cells. Circ Res 91 (2002) 570-576
11. Koji Y., Tomiyama H., Ichihashi H., et al. Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 94 (2004) 868-872
12. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 1997;20:1183-97.
14. McDermott M.M., Criqui M.H., Liu K., et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 32 (2000) 1164-1171
15. Breen J.F., Sheedy P.F., Schwartz R.S., et al. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology 185 (1992) 435-439
16. Carr J.J., Danitschek J.A., Goff D.C., et al. Coronary artery calcium quantification with retrospectively gated helical CT: protocols and techniques. Int J Cardiovasc Imaging 17 (2001) 213-220
17. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 (2005) 35-43
18. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
19. Cushman M., Cornell E.S., Howard P.R., Bovill E.G., and Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41 (1995) 264-270
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Holvoet P., Donck J., Landeloos M., et al. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemostasis 76 (1996) 663-669
22. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
23. Holvoet P., Kritchevsky S.B., Tracy R.P., et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53 (2004) 1068-1073
24. Oki T., Kitaura J., Eto K., et al. Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen. J Immunol 176 (2006) 52-60
25. Kelley J., Hemontolor G., Younis W., et al. Mast cell activation by lipoproteins. Meth Mol Biol 315 (2006) 341-348
26. Fontana L., Giagulli C., Cominacini L., et al. Beta2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes. Circulation 106 (2002) 2434-2441
27. Lobbes M.B., Lutgens E., Heeneman S., et al. Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 187 (2006) 18-25
28. Mackinnon A.D., Jerrard-Dunne P., Sitzer M., et al. Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke 35 (2004) 2150-2154
29. Thomas J.B., Antiga L., Che S.L., et al. Variation in the carotid bifurcation geometry of young versus older adults: implications for geometric risk of atherosclerosis. Stroke 36 (2005) 2450-2456
30. Doherty T.M., Asotra K., Fitzpatrick L.A., et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 100 (2003) 11201-11206
31. Sangiorgi G., Rumberger J.A., Severson A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31 (1998) 126-133
32. Bird C.E., Criqui M.H., Fronek A., et al. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4 (1999) 15-21
33. Fisher C.M., Burnett A., Makeham V., et al. Variation in measurement of ankle-brachial pressure index in routine clinical practice. J Vasc Surg 24 (1996) 871-875
34. Leng G.C., Fowkes F.G., Lee A.J., et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313 (1996) 1440-1444
35. Newman A.B., Sutton-Tyrrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270 (1993) 487-489
36. Vogt M.T., Cauley J.A., Newman A.B., Kuller L.H., and Hulley S.B. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 270 (1993) 465-469
37. Meisinger C., Baumert J., Khuseyinova N., Loewel H., and Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112 (2005) 651-657
38. Johnston N., Jernberg T., Lagerqvist B., Siegbahn A., and Wallentin L. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol 97 (2006) 640-645